Structural alterations in the peptide backbone of beta-amyloid core protein may account for its deposition and stability in Alzheimer's disease.
Alex E. Roher(Barrow Neurological Institute), Melvyn J. Ball(Oregon Health & Science University), Heidi A. Zürcher-Neely(Wayne State University), Robert L. Heinrikson(Wayne State University), R. Wang(Wayne State University), Jonathan D. Lowenson(Wayne State University), Robert J. Cotter(Shirley Ryan AbilityLab), Steven Clarke(Unknown), Cathy Wolkow(Wayne State University), Ilene M. Reardon(Wayne State University)
Cited by 799
Related Papers
Guidelines for the use and interpretation of assays for monitoring autophagy in higher eukaryotes
|Autophagy|2008|2k
Soluble Amyloid β Peptide Concentration as a Predictor of Synaptic Change in Alzheimer's Disease
|American Journal Of Pathology|1999|1.5k
beta-Amyloid-(1-42) is a major component of cerebrovascular amyloid deposits: implications for the pathology of Alzheimer disease.
|Proceedings of the National Academy of Sciences|1993|742
Cerebral Amyloid Angiopathy
|American Journal Of Pathology|1998|682